Amanda Busch


I feel lucky to play a part in helping exciting new companies address challenges and achieve their goals.

Amanda Coleman Busch's practice includes the representation of emerging and high-growth companies and their investors in connection with company formation, venture capital financings, mergers and acquisitions, and public offerings. She represents companies in a wide range of industries.

Download full bio 


  • Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion 

  • Principia Biopharma – $122 Million IPO 

  • ShotSpotter – $30.8 Million IPO 

  • New Relic Completes $132 Million Initial Public Offering 

  • New Relic Completes $132 Million Initial Public Offering  

  • View all


    Spending time with my family, enjoying the outdoors.

  • University of Chicago Law School
    JD, 2009

  • Baylor University
    MAC, 2003

  • Baylor University
    BBA, 2002

Admissions & Credentials